Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings.: Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy.

Jonathan Douxfils; Jean-Michel Foidart; Ulysse Gaspard; Guillaume Chatel; Mélanie Taziaux; Maud Jost; Céline Gérard; Laure Morimont

doi:10.5114/pm.2023.128815

Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy.

Jonathan Douxfils, Jean-Michel Foidart, Ulysse Gaspard, Guillaume Chatel, Mélanie Taziaux, Maud Jost, Céline Gérard, Laure Morimont

Résultats de recherche: Contribution à un journal/une revue › Article › Revue par des pairs

29 Téléchargements (Pure)

langue originale	Anglais
Pages (de - à)	117-119
Nombre de pages	3
journal	Przeglad menopauzalny = Menopause review
Volume	22
Numéro de publication	2
Les DOIs	https://doi.org/10.5114/pm.2023.128815
Etat de la publication	Publié - juin 2023

SDG des Nations Unies

Ce résultat contribue à ou aux Objectifs de développement durable suivants

Accès au document

10.5114/pm.2023.128815

9663-2023-DouxfilsVersion finale publiée, 150 KB

Autres fichiers et liens

Lien vers la publication sur Scopus

1 Terminé
1 Actif

Clinical Pharmacology Research Group
Douxfils, J. (Promoteur), Dogne, J.-M. (Promoteur), Musuamba Tshinanu, F. (Promoteur), Masereel, B. (Promoteur), Wieërs, G. (Promoteur), Haguet, H. (Chercheur), RONVAUX, L. (Chercheur), Donis, N. (Chercheur), Morimont, L. (Chercheur), Evrard, J. (Chercheur), Siriez, R. (Chercheur), Gillot, C. (Chercheur), FAVRESSE, J. (Chercheur), BOUVY, C. (Chercheur), Djokoto, H. (Chercheur), Didembourg, M. (Chercheur), David, C. (Rôle de support), Melchionda, S. (Rôle de support), Maloteau, V. (Technicien), Boucher, A.-Y. (Technicien), Devel, P. (Technicien), Modaffari, E. (Technicien), Vandeputte, M. (Technicien), De Messemaeker, A. (Secrétaire), Decarpentrie, J. (Chercheur), Vassart, J. (Chercheur) & De Groote, A. (Chercheur)
1/04/22 → …
Projet: Axe de recherche
The HIC Project : Evaluation of hormone-induced coagulopathy
Dogne, J.-M. (Promoteur), Douxfils, J. (Promoteur), Morimont, L. (Chercheur), Didembourg, M. (Chercheur) & Evrard, J. (Chercheur)
1/09/19 → 31/08/23
Projet: Recherche

Contient cette citation

Douxfils, J., Foidart, J.-M., Gaspard, U., Chatel, G., Taziaux, M., Jost, M., Gérard, C., & Morimont, L. (2023). Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy. Przeglad menopauzalny = Menopause review, 22(2), 117-119. https://doi.org/10.5114/pm.2023.128815

Douxfils, Jonathan ; Foidart, Jean-Michel ; Gaspard, Ulysse et al. / Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy. Dans: Przeglad menopauzalny = Menopause review. 2023 ; Vol 22, Numéro 2. p. 117-119.

@article{9f6d859831034140a19e75f946d788c8,

title = "Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings.: Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy.",

author = "Jonathan Douxfils and Jean-Michel Foidart and Ulysse Gaspard and Guillaume Chatel and M{\'e}lanie Taziaux and Maud Jost and C{\'e}line G{\'e}rard and Laure Morimont",

year = "2023",

month = jun,

doi = "10.5114/pm.2023.128815",

language = "English",

volume = "22",

pages = "117--119",

journal = "Przeglad menopauzalny = Menopause review",

issn = "1643-8876",

publisher = "Termedia Publishing House Ltd.",

number = "2",

}

Douxfils, J, Foidart, J-M, Gaspard, U, Chatel, G, Taziaux, M, Jost, M, Gérard, C & Morimont, L 2023, 'Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy.', Przeglad menopauzalny = Menopause review, VOL. 22, Numéro 2, p. 117-119. https://doi.org/10.5114/pm.2023.128815

Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy. / Douxfils, Jonathan; Foidart, Jean-Michel; Gaspard, Ulysse et al.
Dans: Przeglad menopauzalny = Menopause review, Vol 22, Numéro 2, 06.2023, p. 117-119.

Résultats de recherche: Contribution à un journal/une revue › Article › Revue par des pairs

TY - JOUR

T1 - Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings.

T2 - Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy.

AU - Douxfils, Jonathan

AU - Foidart, Jean-Michel

AU - Gaspard, Ulysse

AU - Chatel, Guillaume

AU - Taziaux, Mélanie

AU - Jost, Maud

AU - Gérard, Céline

AU - Morimont, Laure

PY - 2023/6

Y1 - 2023/6

UR - http://www.scopus.com/inward/record.url?scp=85171192980&partnerID=8YFLogxK

U2 - 10.5114/pm.2023.128815

DO - 10.5114/pm.2023.128815

M3 - Article

C2 - 37674929

SN - 1643-8876

VL - 22

SP - 117

EP - 119

JO - Przeglad menopauzalny = Menopause review

JF - Przeglad menopauzalny = Menopause review

IS - 2

ER -

Douxfils J, Foidart JM, Gaspard U, Chatel G, Taziaux M, Jost M et al. Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy. Przeglad menopauzalny = Menopause review. 2023 juin;22(2):117-119. doi: 10.5114/pm.2023.128815

Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy.

SDG des Nations Unies

Accès au document

Autres fichiers et liens

Projets

Clinical Pharmacology Research Group

The HIC Project : Evaluation of hormone-induced coagulopathy

Contient cette citation